Testosterone and obesity
DM Kelly, TH Jones - Obesity Reviews, 2015 - Wiley Online Library
Testosterone is a key hormone in the pathology of metabolic diseases such as obesity. Low
testosterone levels are associated with increased fat mass (particularly central adiposity) …
testosterone levels are associated with increased fat mass (particularly central adiposity) …
Interaction between gut microbiota and sex hormones and their relation to sexual dimorphism in metabolic diseases
JA Santos-Marcos, M Mora-Ortiz… - Biology of sex …, 2023 - Springer
Metabolic diseases, such as obesity, metabolic syndrome (MetS) and type 2 diabetes (T2D),
are now a widespread pandemic in the developed world. These pathologies show sex …
are now a widespread pandemic in the developed world. These pathologies show sex …
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
PW Kantoff, CS Higano, ND Shore… - … England Journal of …, 2010 - Mass Medical Soc
Background Sipuleucel-T, an autologous active cellular immunotherapy, has shown
evidence of efficacy in reducing the risk of death among men with metastatic castration …
evidence of efficacy in reducing the risk of death among men with metastatic castration …
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and …
ADT was first used in prostate cancer for patients with overt metastatic disease, 7 and it
remains the mainstay of therapy for this group. ADT combined with external-beam radiation …
remains the mainstay of therapy for this group. ADT combined with external-beam radiation …
Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review
Purpose Androgen-deprivation therapy is a commonly used treatment for men with prostate
cancer; however, the adverse effects can be detrimental to patient health and quality of life …
cancer; however, the adverse effects can be detrimental to patient health and quality of life …
Metabolic complications of androgen deprivation therapy for prostate cancer
PJ Saylor, MR Smith - The Journal of urology, 2009 - Elsevier
PURPOSE: Androgen deprivation therapy has a variety of well recognized adverse effects
including vasomotor flushing, loss of libido, fatigue, gynecomastia, anemia and …
including vasomotor flushing, loss of libido, fatigue, gynecomastia, anemia and …
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study
Targeting androgen receptor (AR) axis signaling by disrupting androgen-AR interactions
remains the primary treatment for metastatic prostate cancer. Unfortunately, all men develop …
remains the primary treatment for metastatic prostate cancer. Unfortunately, all men develop …
The metabolic syndrome in cancer survivors
EC De Haas, SF Oosting, JD Lefrandt… - The lancet …, 2010 - thelancet.com
The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an
important connection between cancer treatment and its common late effect of cardiovascular …
important connection between cancer treatment and its common late effect of cardiovascular …
Obesity and male hypogonadism: Tales of a vicious cycle
Obesity prevalence, particularly in children and young adults, is perilously increasing
worldwide foreseeing serious negative health impacts in the future to come. Obesity is linked …
worldwide foreseeing serious negative health impacts in the future to come. Obesity is linked …
Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy
EJ Hamilton, E Gianatti, BJ Strauss… - Clinical …, 2011 - Wiley Online Library
Objective Androgen deprivation therapy (ADT) for prostate cancer is associated with
increases in fat mass and risk of type 2 diabetes; however, the relationship between sex …
increases in fat mass and risk of type 2 diabetes; however, the relationship between sex …